Home
Valenta Pharm

Valenta Pharm Market Share Analysis for December 2025

Health > Biotechnology and Pharmaceuticals

Domainvalentapharm.com

Year Founded1997

Employees51 - 200

Annual Revenue$15M - $25M

Valenta Pharm

Valenta Pharm (including company regionals)

valentapharm.com

See more website traffic and engagement information

Valenta Pharm Revenue up to December 2025 is 15M - 25M

revenue generated by Valenta Pharm top domains

Valenta Pharm top domains revenue over 3 years

Revenue for Valenta Pharm top domains

valentapharm.com15M - 25M

See more with Sales Intelligence

Total visits to Valenta Pharm's top domains

Understand Valenta Pharm market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

valentapharm.com59.8K

See more with Sales Intelligence

Avg. visit duration in Valenta Pharm's top domains

Analyze Valenta Pharm engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

valentapharm.com00:01:21

See more with Sales Intelligence

Avg. pageviews on Valenta Pharm's top domains

See how Valenta Pharm keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

valentapharm.com1.63

See more with Sales Intelligence

Valenta Pharm top competitors by domain

Top similar sites in December 2025, ranked by their affinity

materiamedica.ruCompany NameMateria Medica HoldingEmployees1001 - 5000HQRussia, MoscowAnnual revenue$100M - $200MTotal visits52KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Valenta Pharm

These are the website technologies, by industry, used by Valenta Pharm top domains

Payment & Currencies (21)

PayPal

Advertising (3)

PubMatic

Conversion & Analytics (3)

Google Analytics

Widget (3)

Google Maps

More Technologies

7

See all

News & Signals from Valenta Pharm

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsValentapharm launches Early Access Program for the use of Kinesia.Valenta Pharm announced the launch of its Early Access Program for the use of Kinesia(R).

NewsValentapharm launches digital product.The development and cheapening of new technologies, access to information about trends and new products form a significant demand for consumers, supporting an active and healthy lifestyle Valenta Pharm, understanding the needs of modern society, starts a new line of business and launches its first digital product.

NewsValentapharm hires Snezhana Chernogortseva as Deputy General Director for Marketing and Sales.The Russian pharmaceutical innovation company Valenta Pharm announces the appointment of Snezhana Chernogortseva, Deputy General Director for Marketing and Sales.